| Literature DB >> 35386765 |
Biruk Adie Admass1, Hailu Yimer Tawye1, Nigussie Simeneh Endalew1, Abraham Tarekegn Mersha1, Debas Yaregal Melesse1, Misganaw Mengie Workie1, Moges Gashaw1, Yonas Admasu Ferede1.
Abstract
Background: Post-operative nausea and vomiting (PONV) are common and distressing to patients. This common anesthetic and surgical side effect has been reported to increase patient dissatisfaction and can be more distressing to patients than post-operative pain. It has multi-factorial causes: patient, anesthesia and surgery related risk factors have been identified. Prevention of PONV is important since it has psychological and physical effects, and it can also cause severe complications. Objective: To determine the level of practice of PONV prophylaxis usage for caesarean section.Entities:
Keywords: Caesarean section; Nausea; Post-operative; Vomiting; antiemetics; prophylaxis
Year: 2022 PMID: 35386765 PMCID: PMC8977925 DOI: 10.1016/j.amsu.2022.103399
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Standards for post-operative nausea and vomiting (PONV) prevention.
| SN. | Standards | Target (%) | Evidence | Data source |
|---|---|---|---|---|
| 1. | Patient's risk for post-operative nausea and vomiting should be stratified | 100 | SAMBA | Chart |
| 2. | The base line risk reduction strategies for patient's nausea and vomiting should be taken | 100 | SAMBA | Chart |
| 3. | No ant emetic prophylaxis is administered to a patient who is at low risk for PONV | 100 | SAMBA | Chart |
| 4. | The anti-emetic prophylaxis should be administered using 1–2 agents to a patient at medium risk for PONV | 100 | SAMBA | Chart |
| 5. | The anti-emetic prophylaxis should be administered using ≥2 (multi modal) agents to a patient at high risk for PONV | 100 | SAMBA | Chart |
| 6. | The anti-emetic agent should be provided to patients with PONV who did not receive prophylaxis or in whom prophylaxis is failed | 100 | SAMBA | Interview & chart |
| 7. | A clinician should be adhered to the local evidence based guideline for PONV prevention | 100 | SAMBA | Interview |
SAMBA: Society for ambulatory anesthesiology, PONV: Postoperative nausea and vomiting.
Tool for PONV prevention.
| SN | Questionnaire | Response | ||
|---|---|---|---|---|
| Yes | No | NA | ||
| 1 | Risk of the patient for PONV was stratified | |||
| 2 | The base line risk reduction strategies for patient's PONV was taken | |||
| 3 | No prophylaxis administered to a patient who is at low risk for PONV | |||
| 4 | Prophylaxis administered using 1–2 agents to patients at medium risk for PONV | |||
| 5 | Prophylaxis administered using ≥2 agents to patients at high risk for PONV | |||
| 6 | Anti-emetic treatment provided to patients with PONV who did not receive prophylaxis or in whom prophylaxis is failed | |||
| 7 | Adherence of anaesthetist to the local guideline for prevention of PONV | |||
NA: Not applicable, PONV: Postoperative nausea and vomiting.
Socio demographic characteristics of patients from March 1 to March 30, 2021, (N = 100).
| Characteristics | Frequency(n) | Percentage (%) |
|---|---|---|
| Sex | ||
| | 53 | 53% |
| | 47 | 47% |
| Age (years) | ||
| | 12 | 12% |
| | 74 | 74% |
| | 14 | 14% |
| History of smoking | ||
| | 4 | 4% |
| | 96 | 96% |
| History of motion sickness | ||
| | 23 | 23% |
| | 77 | 77% |
Fig. 1Percentage of parturients get the standard care from March 1 to March 30, 2021, (N = 100).
Frequency distribution of interviewed and observed participants based of the standards of PONV prevention from March 1 to March 30, 2021, (N = 100).
| Standards | No. of patients as per category | N (%) of patients care received as per the standard |
|---|---|---|
| Risk of the patient for PONV was stratified | 100 | 68 (68%) |
| Base line risk reduction strategies for patient's PONV was taken | 100 | 81 (81%) |
| No prophylaxis administered to a patient who is at low risk for PONV | 21 | 3 (14%) |
| Prophylaxis administered using 1–2 agents to patients at medium risk for PONV | 33 | 27 (82%) |
| Prophylaxis administered using ≥2 agents (multi modal) to patients at high risk for PONV | 25 | 19 (76%) |
| Anti-emetic treatment provided to patients with PONV who did not receive prophylaxis or in whom prophylaxis is failed | 6 | 1 (17%) |
| Adherence of anaesthetist to the local guideline for prevention of PONV | 100 | 47 (47%) |
PONV: Postoperative nausea and vomiting.